ArticleBioImpacts : BI2023

Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells.

Mitra Torabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.